These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34433917)

  • 1. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.
    Xu LP; Lu PH; Wu DP; Sun ZM; Liu QF; Han MZ; Zhang X; Song YP; Song XM; Hu JD; Huang H; Lai YR; Wan DM; Chen J; Li CF; Xia LH; Wang JB; Liu DH; Huang XJ;
    Bone Marrow Transplant; 2021 Dec; 56(12):2940-2947. PubMed ID: 34433917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group.
    Xu LP; Lu DP; Wu DP; Jiang EL; Liu DH; Huang H; Sun ZM; Li NN; Liu QF; Zhang X; Lai YR; Song YP; Song XM; Liu SX; Zhang YC; Luo CJ; Xia LH; Niu T; Yu Y; Zhang XH; Tang XW; Luo Y; Huang XJ;
    Transplant Cell Ther; 2023 Feb; 29(2):136.e1-136.e7. PubMed ID: 36402457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.
    Xu LP; Lu PH; Wu DP; Huang H; Jiang EL; Liu DH; Cao WJ; Zhang X; Fu YW; Li NN; Chen XC; Zhu XY; Liu QF; Xia LH; Zhang YC; Xu YJ; Li FC; Hu J; Liu SX; Liu RR; Ma XD; Tang XW; Luo Y; Zhang XH; Huang XJ;
    Bone Marrow Transplant; 2024 Dec; 59(12):1726-1734. PubMed ID: 39322652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.
    Xu L; Chen H; Chen J; Han M; Huang H; Lai Y; Liu D; Liu Q; Liu T; Jiang M; Ren H; Song Y; Sun Z; Wang J; Wu D; Zhou D; Zou P; Liu K; Huang X
    J Hematol Oncol; 2018 Mar; 11(1):33. PubMed ID: 29495966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.
    Zhang XH; Chen J; Han MZ; Huang H; Jiang EL; Jiang M; Lai YR; Liu DH; Liu QF; Liu T; Ren HY; Song YP; Sun ZM; Tang XW; Wang JM; Wu DP; Xu LP; Zhang X; Zhou DB; Huang XJ
    J Hematol Oncol; 2021 Sep; 14(1):145. PubMed ID: 34526099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
    Giebel S; Boumendil A; Labopin M; Seesaghur A; Baron F; Ciceri F; Esteve J; Gorin NC; Savani B; Schmid C; Wetten S; Mohty M; Nagler A
    Ann Hematol; 2019 Oct; 98(10):2389-2398. PubMed ID: 31392462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2020 Dec; 99(12):2911-2925. PubMed ID: 33000361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
    Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.
    Liu H; Zhai X; Song Z; Sun J; Xiao Y; Nie D; Zhang Y; Huang F; Zhou H; Fan Z; Tu S; Li Y; Guo X; Yu G; Liu Q
    J Hematol Oncol; 2013 Feb; 6():15. PubMed ID: 23394705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable Outcomes After Alternative and Matched Sibling Donor Hematopoietic Stem Cell Transplantation and the Role of Molecular Measurable Residual Disease for Acute Myeloid Leukemia in Elderly Patients.
    Cho BS; Yahng SA; Min GJ; Park S; Park SS; Shin SH; Jeon YW; Yoon JH; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim M; Kim Y; Kim HJ
    Transplant Cell Ther; 2021 Sep; 27(9):774.e1-774.e12. PubMed ID: 34082159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia.
    Konishi T; Doki N; Nagata A; Yamada Y; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Yasuda S; Yoshioka K; Inamoto K; Toya T; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Ann Hematol; 2020 Jan; 99(1):147-155. PubMed ID: 31786646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group.
    Moore AS; Shaw PJ; Hallahan AR; Carter TL; Kilo T; Nivison-Smith I; O'Brien TA; Tapp H; Teague L; Wilson SR; Tiedemann K
    Med J Aust; 2009 Feb; 190(3):121-5. PubMed ID: 19203307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.
    Passweg JR; Baldomero H; Bader P; Bonini C; Duarte RF; Dufour C; Gennery A; Kröger N; Kuball J; Lanza F; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M
    Bone Marrow Transplant; 2017 Jun; 52(6):811-817. PubMed ID: 28287639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.
    Ahmed SO; Ghavamzadeh A; Zaidi SZ; Baldomero H; Pasquini MC; Hussain F; Alimoghaddam K; Almohareb F; Ayas M; Hamidieh A; Mahmoud HK; Elhaddad A; Ben Othman T; Abdelkefi A; Sarhan M; Abdel-Rahman F; Adil S; Alkindi S; Bazarbachi A; Benchekroun S; Niederwieser D; Horowitz M; Gratwohl A; El Solh H; Aljurf M
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1352-61. PubMed ID: 21440654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia.
    Lin CH; Su YJ; Hsu CY; Wang PN; Teng CJ
    Transpl Infect Dis; 2019 Aug; 21(4):e13096. PubMed ID: 31004545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.
    Miano M; Labopin M; Hartmann O; Angelucci E; Cornish J; Gluckman E; Locatelli F; Fischer A; Egeler RM; Or R; Peters C; Ortega J; Veys P; Bordigoni P; Iori AP; Niethammer D; Rocha V; Dini G;
    Bone Marrow Transplant; 2007 Jan; 39(2):89-99. PubMed ID: 17213848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.